In this study we examine whether a somatic cell, once returned to a pluripotent state, gains the ability to reprogram other somatic cells. We reprogrammed mouse embryonic fi broblasts by viral induction of oct4, sox2, c-myc, and klf-4 genes. Upon fusion of the resulting iPS cells with somatic cells harboring an Oct4-GFP transgene we observed, GFP expression along with activation of Oct4 from the somatic genome, expression of key pluripotency genes, and positive immunostaining for Oct4, SSEA-1, and alkaline phosphatase. The iPS-somatic hybrids had the ability to differentiate into cell types indicative of the three germ layers and were able to localize to the inner cell mass of aggregated embryos. Furthermore, ntES cells were used as fusion partners to generate hybrids, which were also confi rmed to be reprogrammed to a pluripotent state. These results demonstrate that once a somatic cell nucleus is reprogrammed, it acquires the capacity and potency to reprogram other somatic cells by cell fusion and shares this functional property with normal embryonic stem (ES) cells.
Introduction
T he somatic genome can be reprogrammed to a pluripotent state by a number of methods, including somatic cell nuclear transfer (SCNT), cell fusion to an embryonic stem cell, and viral transduction of reprogramming factors resulting in induced pluripotent stem cells (iPS). All three processes have helped to delineate the reprogramming process.
First, SCNT, which involves the transfer of a differentiated nucleus to an oocyte from which the maternal DNA has been removed, has been shown to completely reprogram differentiated mammalian nuclei to produce live offspring [1] . Even though NT embryonic stem (ES) cells can be derived from cloned mouse embryos [2] , to date no human ntES cells have been derived. Second, reprogramming by cell fusion involves the hybridization of 2 different cells/ genomes, and in most hybrids the phenotype of the lessdifferentiated fusion partner dominates the phenotype of the more-differentiated partner. ES cells have the ability to reprogram the somatic genome following cell fusion with both mouse [3] and human ES cells [4, 5] . Following cell fusion, the ES-somatic cell hybrids assume hallmarks of pluripotent cells including growth characteristics, gene expression profi les, and differentiation potential. However, due to their increased ploidy they contribute minimally to the late gestation epiblast [3] and chimeras [6] .
More recently, the viral delivery and expression of the transcription factors; Oct4 and Sox2, with either c-Myc, and Klf-4 in mouse [7] , and human [8] , or with Nanog and Lin28 [9] , have been shown to induce pluripotency to somatic cells, giving rise to iPS cells. To reduce the number of viral constructs used and/or minimize viral integration, combinations of these key reprogramming factors can be replaced with either chemical compounds or endogenous expression in somatic cells [10] [11] [12] [13] , or delivered by nonintegrating viruses [14, 15] . iPS cells have been shown to be similar to ES cells in terms of gene expression profi le, epigenetic state, differentiation potential both in vitro and in vivo, ability to give rise to germ line competent chimeras and can be used to generate autologous cells for transplantation studies [7] [8] [9] [16] [17] [18] [19] . In a preliminary study, iPS cells have been shown to reprogram somatic cells by cell fusion [20] , however the reprogramming abilities of de-differentiated cells has not been described in detail.
Here, we conducted an in-depth study to determine whether a somatic cell, once returned to a pluripotent state, gains the ability to reprogram other somatic cells. To test this hypothesis, we investigated the reprogramming abilities of effi ciency was calculated by subtracting the double positive value in mock fusions from the fusion value. As a control for cell fusion based reprogramming of OG2 MEFs, mES D3 cells were used as fusion partners in parallel experiments.
PCR
Genomic DNA was extracted using the DNeasy Blood and Tissue kit (Qiagen, Hilden, Germany) and used for amplifi cation of neomycin and GFP sequences by PCR with the following primer pairs. Neo F agacaatcggctgctctgat, Neo R. caatagcagccagtcccttc, GFP F GACGACGGCAACTACAAGA, GFP R GATGCCGTTCTTCTGCTT. The PCR cycle parameters included an initial denaturation at 94°C for 5 min followed by 30 cycles of denaturation at 94°C for 1 min, annealing at 58°C for 45 s and extension at 72°C for 1 min, followed by fi nal extension at 72°C for 5 min. PCR products were run on a 1% agarose gel at 100 V for 1 h.
RT-PCR and SNP analysis
Total RNA was extracted from cells using the RNeasy kit (Qiagen) according to the manufacturer's instructions. To remove contaminating genomic DNA the resulting total RNA was subjected to DNaseI treatment using the DNAfree kit (Ambion, Austin, TX). About 2 μg of RNA was used to synthesize cDNA using the SuperScript III reverse transcriptase kit (Invitrogen). cDNA samples were subjected to PCR amplifi cation with the following primer pairs:
Oct4 F: GTTCAGCCAGACCACCATCT, R:CCTGGGAAAGG TGTCCTGTAG Rex1 F: GGACTAAGAGCTGGGACACG, R:GCTGCTTCCTT CTTGAACAAT Nanog F: TCAAGGACAGGTTTCAGAAGCA, R:GCTGGGA TACTCCACTGGTG Sox2 F: GAGGAGAGCGCCTGTTTTT, R:GGAGATCTGGCG GAGAATAG SPARC F: AATTTGAGGACGGTGCAGAGG, R:GGTTGTTG CCCTCATCTCTCT β-actin F: GGAATCCTGTGGCATCCATGAAAC, R:AAAAC GCAGCTCAGTAACAGTCCG For Oct4 SNP analysis cDNA was amplifi ed using the Oct3/4-S9: TCTTTCCACCAGGCCCCCGGCTC [7] and oct4 RNA R: GCAAACTGTTCTAGCTCCTTCT, to amplify a 469 bp endogenous Oct4 product, avoiding amplifi cation of the exogenous viral construct. PCR products were digested with BamHI for 4 h before running on an agarose gel. Digested samples were run on a 3.5% low melt agarose gel and undigested Oct4 bands were excised and DNA extracted using the QIAEXII kit following manufacturer's instructions and sequenced by The Gandel Charitable Trust Sequencing Centre, Clayton Australia (Applied Biosystems ABIPRISM™ 377 DNA Sequencer).
Oct4 methylation analysis
Genomic DNA isolated from the various cell lines were processed the MethylEasy Xceed Kit (Human Genetic Signatures, North Ryde, New South Wales, Australia) for bisulfi te conversion. Hemi-nested primers O4 B4 S 116781 F1 TTGAGGAGTGGTTTTAGAA ATAATTGGTAT and O4 B4 S 117317 R1 CCCAACCCTACT CCAACCCTACTA, followed by both iPSCs and ntES cells by using them as fusion partners with somatic cells. We generated and characterized iPS cells from mouse embryonic fi broblasts (MEFs) and fused them to OG2 MEFs harboring an Oct4-GFP reporter gene. In the resulting iPS-somatic cell hybrids, the Oct4-GFP transgene along with the endogenous Oct4 gene were reactivated, pluripotency specifi c genes expressed, and stained positive for Oct4, SSEA-1 and alkaline phosphatase. The iPS-somatic hybrids had the ability to differentiate into multiple lineages and localized to the inner cell mass of aggregated embryos. We further tested the ability of a de-differentiated cell to reprogram a somatic cell by using ntES cells as fusion partners. We concluded that a somatic cell, once reprogrammed, has the ability to reprogram other somatic cells by cell fusion and shares this functional property with normal ES cells.
Materials and Methods

Cell culture and differentiation
Feeder-independent mouse ESD3, iPS cells, and iPSsomatic cell hybrids were cultured in ES media: DMEM (Invitrogen, Carlsbad, CA) supplemented with 15% Hyclone™ fetal bovine serum, 1 mM l-glutamine (Invitrogen), 0.1 mM b-mercaptoethanol (Sigma, St. Louis, MO), 1,000 U/mL LIF (Chemicon, Temecula, CA), 1% nonessential amino acids (Invitrogen) and 0.5% penicillin-sreptomycin (Invitrogen). Mouse embryonic fi broblasts were cultured in the same medium minus LIF and b-mercaptoethanol. Cultures were maintained in a humidifi ed incubator at 37°C, with 5% CO 2 /95% air. For embryoid body formation 1 × 10 6 cells were plated on Petri dishes in ES media minus LIF for 7 days. To examine teratoma formation, 1-2 × 10 6 cells were injected into the rear leg muscle of 4-to 6-week-old severe combined immunodefi cient (SCID) mice. After 4 weeks, the teratomas were excised and fi xed in 4% paraformaldehyde, embedded in paraffi n, sectioned at 5 uM and stained with hematoxylin and eosin by the MIMR Histology Laboratory core facility.
iPS generation and cell fusion
iPS cells were generated from MEFs from QS/Rosa26 mice as previously described [21] . Following viral transduction iPS colonies were picked by morphology and expanded clonally on MEF feeder layers for further analysis. iPSsomatic cell hybrids were produced by Polyethylene glycol (PEG) mediated cell fusion performed in a 4-well Nunc tissue culture plate as previously described [22] . In brief, iPS cells were plated at 0.5 × 10 6 per cellular fi bronectin (Sigma) coated well and cultured overnight. Around 1 × 10 6 OG2 MEFs were centrifuged onto the dense monolayer at 400g for 10 min. The culture medium was removed and fusion performed by adding 500 μL of 50% PEG 1500 /150 mM HEPES and incubated at room temperature for 2 min. The PEG was removed, the cells washed 4 times in calcium-and-magnesium-free PBS and allowed to recover in ES medium in the incubator for at least 4 h before the contents of the plate were trypsinized and plated in 2 × 6 cm dishes for further culture. antibodies at 1:100 dilution overnight at 4°C. Following 3 washes with PBS, the slides were incubated at room temperature for 1 h with secondary antibodies goat α-mouse IgM Alexa 594 or goat α-mouse IgG Alexa 594 (Invitrogen, Australia), respectively, diluted 1:1,000 in blocking solution. Following 3 washes with PBS the slides were mounted in Vectashield + DAPI) (Vector Laboratories, Burlingame, CA) with a coverslip. Alkaline phosphatase activity was detected with an AP kit (Chemicon) according to the manufacturer's instructions.
Embryo isolation and culture and embryo aggregations
Female mice (3-5 weeks) were superovulated by injections of 5IU of Pregnant Mare Serum Gonadotrophin (PMSG) 48 h prior to, and 5IU (hCG) immediately before being housed with stud F 1 males for mating overnight. Midnight was arbitrarily assigned as time of mating. The following day, plugged females were sacrifi ced and embryos isolated from the reproductive tract by manual dissection of the ampulla in M2 handling medium (Chemicon). Surrounding O4 B4 S 116828 F2 GGGTAA GTAAGAATTGAGGAGTGGTTT and O4 B4 S 117317 R1, were designed to selectively amplify the fully converted genomic DNA templates after 2 rounds of PCR. PCR for each sample was performed in triplicate and then pooled for cloning into pGEMT-Easy vector (Promega, Madison, WI). PCR cycling conditions were as follows: denaturation at 95°C for 4 min, followed by 5 cycles at 93°C for 30 s, annealing at 57°C for 60 s, and extension at 72°C for 60 s, followed by a fi nal extension of 10 min. Purifi ed PCR products were amplifi ed for a second time using the hemi-nested primers. Eight clones from each genomic DNA template were sequenced and the methylation status was determined using BiQ Analyzer software [23] .
Histochemistry and immunohistochemistry
Cells were cultured in 4-well glass culture slides (BD Falcon, Bedford, MA) and fi xed in 4% paraformaldehyde for 10 min, washed 3 times with PBS and incubated with blocking solution (5% goat serum, 1% BSA in PBS) or blocking solution with 0.1% Triton-X for SSEA-1 and Oct4 primary antibodies, respectively, before being exposed to the primary previously described [21] . A number of phase bright compact colonies similar in morphology to those of mouse ES cells were picked, expanded and further characterized (Supplementary Fig. 1 ; Supplementary materials are available online at http:// www.liebertpub.com/). The iPS clones were shown to have a normal diploid chromosome count and pluripotential was shown by alkaline phosphatase activity, Oct4 and SSEA1 antibody staining, gene expression profi ling, EB formation, and teratoma formation where cells from all 3 germ layers were observed ( Supplementary Fig. 1 ). Polyethylene glycol (PEG) mediated cell fusion was performed with iPSC clone 2 and MEFs isolated from OG2 transgenic mice, which contain a GFP reporter under the control of the Oct4 promoter region (Fig. 1A) . The fusion efficiency was determined to be 1.26% ± 0.69 (N = 3) (Fig. 1B) . Oct4-GFP reactivation was observed in cells within 72 h of fusion, a time point where mES D3 cells were also observed to reactivate the transgene in parallel fusions. Five days post fusion, 5 ± 3 (N = 3) GFP +ve colonies were observed (Fig.  1C) , and 3 individual GFP +ve colonies were picked and expanded by enzymatic passaging for further analysis. The hybrid cells grew in tight, phase bright colonies and continued to express the Oct4-GFP transgene from the OG2 MEF genome. The hybrids were confi rmed to have risen from a fusion event from the two parental cell lines by polymerase cummulus cells were digested from zygotes by digestion in M2 medium containing hyaluronidase (Chemicon) before 3 washes in 20 μL droplets of KSOMaa media with BSA under mineral oil and overnight culture. Cultured 2.5 dpc, diploid (2N) embryos were incubated in Tyrodes acid solution and monitored visually for zona pellucida digestion before being washed 3 times in KSOMaa media. Zona-free embryos were individually placed into depressions made in the fl oor of culture dishes with a sterilized darning needle overlayed with a 15-20 μL droplet of KSOMaa culture media. Aggregates of 5-10 donor cells were dropped into the depression in contact with the embryos. Embryos were further cultured in a humidifi ed incubator at 37°C before visualization at 3.5-4.5 days postcoitum. For tetraploid embryo complementation, two cell stage embryos were washed in electrofusion medium consisting of mannitol before fusion of blastomeres with a pulse of direct current at approximately 130 volts to initiate fusion. 
Results
Generation of iPS cells and iPS-somatic cell hybrids
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when they are injected into developing blastocysts or when aggregated with diploid or tetraploid embryos [24] . Both mouse tetraploid ES cells [25] and ES-somatic cell hybrids are also capable of integrating into the inner cell mass of diploid preimplantation blastocysts [3, 6] , however tetraploid cells contribute minimally to chimeras due to their ploidy. Here, we generated tetraploid embryos by electrofusion of blastomeres of 2-cell embryos and aggregated them with the GFP positive iPS-somatic cell hybrids at the 6-8 cell stage before visualization at the blastocyst stage (3.5-4.5 days postcoitum). GFP positive cells were observed to localize to the inner cell mass of aggregated embryos (N = 8), further confi rming the pluripotent nature of iPS-somatic cell hybrids (Fig. 2E) .
Reprogramming of the endogenous Oct4 locus
In addition to the activation of the Oct4-GFP transgene reporter from the somatic genome, we investigated the transcriptional reactivation of endogenous embryonic genes from the somatic chromosomes. Oct4 is a key transcription factor involved in the self renewal and pluripotency of embryonic stem cells [26] . We identifi ed a single nucleotide polymorphism (SNP) in the fi rst exon of the Oct4 gene, whereby a G-residue within a BamHI restriction site of the iPS genome is replaced with an A-residue in the OG2 somatic genome (Fig. 3A) . PCR was used to amplify a 469 bp, the Oct4 transcripts product containing the SNP from cDNA isolated from hybrids and iPS cells, using primers that were specifi c to endogenous Oct4 that did not amplify the viral transcripts [7] . Equal amounts of PCR chain reaction (PCR) for the Neomycin and GFP transgenes from the iPS and MEF parental lines, respectively (Fig. 1D) . The hybrids were also shown to have double the DNA content of the 2 parental cell lines by fl ow cytometry analysis (Fig. 1E) .
Characterization of iPS-somatic cell hybrids
The hybrids were further characterized for their developmental potential in vitro and in vivo. Hybrids were shown to express the pluripotency markers Oct-4, Rex-1, Nanog, and Sox2, while the fi broblast specifi c marker SPARC was extinguished in hybrids ( Fig. 2A) . Furthermore, the 4 exogenous viral factors Oct-4, Sox2, cMyc, and Klf-4 were shown to be switched off in both the iPS and iPS-somatic hybrid clones (Supplementary Fig. 2 ). The hybrids also had high levels of alkaline phosphatase activity (Fig. 2B) , and formed EBs in the absence of LIF (Fig. 2C) . Immunostaining showed the correct localization of pluripotency markers Oct-4 and SSEA-1, to the nucleus and plasma membrane, respectively ( Fig. 2E-2F ), while the Oct4-GFP transgene appeared to be silenced within some cells in iPS-somatic cell hybrid colonies. To confi rm that iPS-somatic hybrids were pluripotent, the 3 clones were injected into the thigh muscle of SCID mice. All mice developed tumors and histological examination revealed that the teratomas from iPS-somatic cell hybrids contained tissues representative of all 3 germ layers. Differentiated tissues observed included primitive neuroectoderm, secretory epithelium, and muscle (Fig. 2D) .
Another characteristic of embryonic stem cells is that they contribute to the inner cell mass and give rise to the epiblast 
Reprogramming of somatic cells by ntES cell fusion
The reprogramming ability of de-differentiated somatic cells was further tested using ntES cells as fusion partners. Previously reported neomycin resistant ntES cells [2] were fused to OG2 MEFs. The resulting GFP expressing hybrid colonies (Fig. 4A) , were shown to express the pluripotency markers Oct-4, Rex-1, Nanog, and Sox2, while the fi broblast specifi c marker SPARC was extinguished (Fig. 4B) . Reprogramming of the somatic genome was confi rmed by activation of the somatic Oct4 allele in hybrids using SNP analysis (Fig. 4C) . Bisulphite genomic sequencing analyses of the Oct4 promoter revealed that ntES-somatic cell hybrids, like ntES cells, were largely unmethylated suggesting demethylation of the OG2 MEF genome following cell fusion (Fig. 4D) . The hybrid colonies also stained positive for Oct-4 and SSEA-1 proteins (Fig. 4E and 4F) . The pluripotent nature of these hybrids was confi rmed by teratoma formation, where tissues representative of all three germ layers were identifi ed (Fig. 4G) .
Discussion
A functional property of pluripotent cells is that they have the capacity to reprogram somatic cells by cell fusion in vitro. In the present study, we have shown in detail that both mouse iPSCs and SCNT derived ntES cells, like ES and EC cells [3, 27] , have the ability to reprogram a somatic genome following cell fusion. This demonstrates that once a somatic cell is reprogrammed/de-differentiated, acquires the capacity and potency to reprogram another somatic cell by cell fusion.
Following cell fusion iPS-somatic cell hybrids adopt a number of ES characteristics including; colony-like morphology, expression of the stem cell markers Oct4, Nanog, Sox2, and Rex-1, while the differentiation marker SPARC is silenced. The hybrids also stain positively for the stem cell markers AP, SSEA1, and Oct4 and give rise to teratomas consisting of tissues from all three germ layers when injected into immunocompromised mice. iPS-somatic cell products were digested with BamHI endonuclease and run on a gel alongside undigested products (Fig. 3B) . The iPS sample was completely digested resulting in 341 bp and 128 bp products, as expected. While both undigested and digested products at 469, 341, and 128 bp were observed in the hybrid sample, to verify that the undigested band at 469 bp was from the OG2 genome, the bands were excised from the gel, sequenced, and confi rmed to contain the A-residue at the SNP location (Fig. 3C) . This was further verifi ed by Tfi I digestion, resulting in only digestion of the somatic genome when an alternate primer set was used (data not shown).
Bisulphite genomic sequencing analyses of the Oct4 promoter revealed that the iPS cells had undergone demethylation following pluripotency induction of the parental NeoR MEF cells (Fig. 3D) . Furthermore, the iPS-somatic cell hybrids, like the iPS and ES cells, were largely unmethylated suggesting demethylation of the OG2 MEF genome following cell fusion. 
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hybrids also localize to the inner cell mass of developing blastocysts. To demonstrate that the somatic genome is reprogrammed following iPS cell fusion, allele-specifi c gene expression analysis was performed and it was confi rmed that the endogenous Oct4 gene was transcribed from the MEF genome. Furthermore, bisulfi te sequencing analysis demonstrated that the Oct4 promoter undergoes demethylation following reprogramming. This demonstrates that the somatic genome is not merely silenced following cell fusion resulting in the dominance of the iPS cell, but it contributes to the hybrid cells transcriptome. Furthermore, it is interesting to note that the reactivation of the somatic Oct4-GFP transgene in iPS-somatic fusions occurred at a similar time to that when ES cells were used as fusion partners. This suggests that iPS cells have similar reprogramming potency abilities to ES cells.
Despite the fact that the 4 exogenous viral factors were switched off in our iPS cells prior to fusion as well as in the iPS-somatic hybrids, it could not be determined whether the factors were reactivated transiently during the fusion process and responsible for the reprogramming of the somatic genome in the iPS-somatic cell hybrids. To conclusively demonstrate that de-differentiated cells gain the ability to reprogram a somatic cell by cell fusion, we used SCNT derived ntES cells in cell fusion experiments. Pluripotential was also shown to be restored to the resulting hybrids by Oct4-GFP transgene reactivation, activation of Oct4 from the somatic genome by SNP analysis, demethylation of the Oct 4 promoter, expression of key pluripotency genes, immunostaining for Oct4, SSEA-1, and alkaline phosphatase, and the ability to differentiate into cell types indicative of the 3 germ layers.
Taken together, this study demonstrates that reprogramming of a somatic cell achieved by either viral induction of pluripotency factors or by SCNT re-establishes not only selfrenewal and pluripotency but also reprogramming capacity, which is another functional feature of embryonic stem cells.
